HeiLongJiang ZBD Pharmaceutical Co., Ltd.SSE: 603567

Report for Q3 2025

Oct 28, 2025 · Issued by HeiLongJiang ZBD Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 28, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-361

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix

Earlier from HeiLongJiang ZBD Pharmaceutical

Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares to Less than 5%Oct 15, 2025
Indicative Announcement on Equity Change of Shareholders with Over 5% Shares Reaching 5%Sep 12, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Aug 29, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingAug 28, 2025
Announcement on Shareholding Reduction Plan for Shareholders Holding More than 5% of SharesAug 20, 2025

Later from HeiLongJiang ZBD Pharmaceutical

Announcement on Renewing Engagement of Accounting FirmNov 26, 2025
Announcement on Obtaining Drug Registration Certificate by the Wholly-owned SubsidiaryDec 3, 2025
Announcement on Providing Additional Guarantee Amount for Wholly-owned SubsidiaryDec 6, 2025
Announcement on Result of Shareholding Reduction by Shareholder with Over 5% SharesDec 11, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Dec 12, 2025

All HeiLongJiang ZBD Pharmaceutical news releases

Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.

Follow HeiLongJiang ZBD Pharmaceutical